MedTrace Logo

Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes

NCT04493177 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 645

Last updated 2023-09-28

No results posted yet for this study

Summary

In order to evaluate the effect of an educational intervention on mothers with gestational diabetes and their offspring in the first 18 months of life, The intervention will be applied to mothers with gestational diabetes, and a group of mothers without diabetes, against a control group with the normal post-partum treatment. Effects on overweight and obesity will be evaluated in both mothers and offspring.

Conditions

  • Gestational Diabetes
  • Overweight and Obesity

Interventions

BEHAVIORAL

Educational intervention

Monthly 45-minute sessions will be held, including dietary, and physical activity modification, early stimulation, exclusive breastfeeding for 6 months and the proper introduction of foods, and other support for the mother. The sessions will be supported by personalized contact by WhatsApp and programmed telephone calls, in addition to conventional treatment.

OTHER

Conventional treatment Guia de Practica Clinica IMSS-029-08

Conventional treatment includes some early stimulation, monthly visits for height/weight measurement of the offspring.

Sponsors & Collaborators

  • Fundacion Rio Arronte

    collaborator UNKNOWN

  • Massachusetts General Hospital

    collaborator OTHER

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Principal Investigators

  • Cesar R Gonzalez Bonilla, PhD · Secretary of Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-25
Primary Completion
2025-08-25
Completion
2025-08-25

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493177 on ClinicalTrials.gov